Harvoni Generic India
Sofosbuvir 400mg and Ledipasvir 90mg
Hetero has received approval form Drug Controller General of India (DCGI) on 8th Dec-2015 for fixed-dose combination Ledipasvir-Sofosbuvir (90mg/400mg) ,
Ledipasvir +Sofosbuvir is a two-drug fixed-dose combination product that contains 90 mg of ledipasvir and 400 mg of sofosbuvir in a single tablet, and sold globally by Gilead Sciences , Inc., under its brand HARVONI ®. It is indicated for the treatment of chronic hepatitis C (CHC) genotype 1 infection in adults.
Natco Ltd ,Hetero Labs and 5 other company form India had signed a non-exclusive licensing agreement with Gilead Sciences earlier in 2015, to manufacture and sell generic versions of its chronic hepatitis C medicines, including generic version of HARVONI ®, in India and other 100 developing countries.
Harvoni Generic India Ledisof & Hepcinat LP
HARVONI ®is a prescription medicine used to treat chronic hepatitis C genotype 1 infection in adults. Click Here for For more information on US FDA Approval
Call : +91 8652561080
This medicine is to be taken strictly under Medical Supervision Only